Clinical value of sulperazon in lung inflammatory therapy
SUN An-min
WANG Wei
Abstract：Objective To investigate the clinical value of sulperazon in the treatment of lung inflam-mation. Methods 200 cases of patients with pulmonary inflammation, including 50 cases of acute pneumoni-a, 40 cases of lung abscess, 20 cases of hepatocellular carcinoma complicated with pneumonia, 30 cases of chronic bronchitis complicated with infection, 30 cases of bronchiectasis with infection, 30 cases of pulmonary heart disease complicated with infection were collected. According to sulperazon using medication , 10 days for a course of treatment, detection of therapeutic effect after two courses of treatment. Results There were 240 strains bacteria which were cultured. Including Klebsiella pneumoniae 52 strains (21.7%), followed by Pseu-domonas aeruginosa 45 strains (18.8%). After treatment of two courses, there were 177 cases (88.5%) effec-tive, including 101 cases cured and 76 cases improved significantly. After treatment ,the clearance of bacteria were mostly above 50%. The clearance to Pseudomonas aeruginosa was highest which was 86.5%, but had low-er clearance to Acinetobacter which was 37.5%. Conclusion Sulperazon has good effect in the treatment of lung inflammation, which has less side effects, low rate of resistance, mainly for infections caused by Gram-negative bacillus.
Keywords：SulperazonPulmonary inflammationClinical value
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 106-108 )